Year in Review: 10 Health Policy Issues for 2023
This fact sheet offers a look back at 10 issues that KFF tracked closely during 2023 in its polling, policy analysis and journalism, including summaries of major findings and news stories.
View the Latest: Vaccines
Filter
-
-
The COVID-19 “Vaccination Line”: An Update on State Prioritization Plans
Issue BriefThis analysis examines the different approaches states are taking to manage the limited initial supply of COVID-19 vaccines and balance the desire to vaccinate those at greatest risk first with the need to ensure a fast and effective statewide vaccination effort. It includes a state data table.
-
Most Hispanic Adults Lean Towards Getting a COVID-19 Vaccine, But Many Younger Adults are Hesitant
News ReleaseA new analysis of KFF COVID-19 Vaccine Monitor survey data finds that most Hispanic adults across the country want to get a COVID-19 vaccine at some point though younger adults are more hesitant, in part because of lower confidence that it is safe and effective. Overall a quarter (26%) of Hispanic adults say they will get a COVID-19 vaccine “as soon as possible” and an additional 43% say they will “wait until it has been…
-
This Week in Coronavirus: January 22 to January 28
Policy WatchDuring the 53rd week since the first coronavirus case appeared in the United States, the world surpassed 100 million COVID-19 cases, with the United States accounting for a quarter of them. The U.S. also accounts for one-fifth (433,200) of the world’s nearly 2.2 million reported deaths.
-
At This Early Stage of the COVID-19 Vaccine Roll-Out, Most Older Adults Have Not Yet Been Vaccinated As Supply Remains Limited
Issue BriefThis analysis looks at vaccination rates among older adults at the state level, and the share of all vaccines administered that have been given to older adults, among states reporting vaccination data by age.
-
Is the End of the Long-Term Care Crisis Within Sight? New COVID-19 Cases and Deaths in Long-Term Care Facilities Are Dropping
Policy WatchThis analysis compares trends in new COVID-19 cases and deaths among nursing facility residents with trends in all other new COVID-19 cases and deaths excluding nursing facility residents through February 7, 2021. This analysis shows a marked divergence in new cases and deaths per week between nursing facility residents and the rest of the US population since December 2020. This drop in new deaths and cases in nursing facility residents coincides with the start of…
-
Trump Administration Drops Medicaid Vaccine Reporting Requirements
Policy WatchThis policy watch describes recent Trump administration changes to Medicaid vaccine reporting requirements and explores what the end of state reporting requirements may mean for how the U.S. tracks childhood vaccinations rates.
-
COVID-19 Vaccine Breakthrough Cases: Data from the States
Policy WatchWe reviewed the websites and other official state sources for all 50 states and D.C. to see which are providing data on COVID-19 breakthrough cases, hospitalizations and deaths, how regularly, and what those data may tell us.
-
Misinformation About COVID-19 Vaccines and Pregnancy is Widespread, Including Among Women Who are Pregnant or Planning to Get Pregnant
News ReleaseMisinformation and confusion about the COVID-19 vaccines and pregnancy remains widespread, with most people – including women who are pregnant or trying to get pregnant – either believing or being uncertain about at least one of three false claims they’ve heard, a new KFF COVID-19 Vaccine Monitor shows. Among women who are pregnant or trying to get pregnant – the group for whom accurate information about the vaccines’ safety before, during and after pregnancy is…
-
COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility
Issue BriefChildren between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.